Michael Crump

18.3k citations
326 papers · 14.4k · 7 hit papers · h-index 60

Impact in

Papers in

Michael Crump

308 papers receiving 13.8k citations

Michael Crump's Hit Papers

Nivolumab+AVD in Advanced-Stage Classic Hodgkin’s Lymphoma 2024 · 99 citations
990+5+11Years since publication4008001.2k

Peers

Michael Crump
Comparison fields: 5 of 144
  • Pathology and Forensic Medicine 6.8k
  • Oncology 2.6k
  • Hematology 992
  • Genetics 481
  • Cancer Research 605
Replace Massimo Federico with:
Massimo Federico Italy
Steven Horwitz United States
John A. Radford United Kingdom
George P. Canellos United States
Jonathan W. Friedberg United States
John William Sweetenham United States
Charalambos Babis Andreadis United States
Franco Cavalli Switzerland
Vittorina Zagonel Italy
Andreas Engert Germany
Michael Crump relative to Massimo Federico Italy Massimo Federico's profile →
Citations per field
00.5×1.6×
Massimo Federico · 1×
Citations per year

Countries citing papers authored by Michael Crump

Since Specialization
Citations

This map shows the geographic impact of Michael Crump's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Crump with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Crump more than expected).

Fields of papers citing papers by Michael Crump

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Crump. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Crump. The network helps show where Michael Crump may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Crump, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Crump Line = papers co-authored together Michael Crump links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 326 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Outcomes in refractory diffuse large B-cell lymphoma: results from the international SCHOLAR-1 study
Hit paper breakdown →
20171352
2
Bortezomib plus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 Trial.
Hit paper breakdown →
20111138
3
Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
Hit paper breakdown →
2009540
4
Pralatrexate in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results From the Pivotal PROPEL Study
Hit paper breakdown →
2011518
5
Randomized Comparison of Gemcitabine, Dexamethasone, and Cisplatin Versus Dexamethasone, Cytarabine, and Cisplatin Chemotherapy Before Autologous Stem-Cell Transplantation for Relapsed and Refractory Aggressive Lymphomas: NCIC-CTG LY.12
Hit paper breakdown →
2014383
6
Glofitamab, a Novel, Bivalent CD20-Targeting T-Cell–Engaging Bispecific Antibody, Induces Durable Complete Remissions in Relapsed or Refractory B-Cell Lymphoma: A Phase I Trial
Hit paper breakdown →
2021346
7 2003308
8 2011307
9 2003296
10 2003241
11 2008235
12 2003234
13 2019230
14 2015191
15 2003167
16 2008157
17 2001150
18 1993147
19 2006140
20 2008140

About Michael Crump

Michael Crump is a scholar working on Pathology and Forensic Medicine, Hematology, Oncology, Cancer Research and Genetics, having authored 326 papers that have together received 14.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (210 papers), Hematopoietic Stem Cell Transplantation (34 papers), Breast Cancer Treatment Studies (19 papers), Acute Myeloid Leukemia Research (15 papers), Chronic Lymphocytic Leukemia Research (11 papers), CAR-T cell therapy research (8 papers), Cancer Treatment and Pharmacology (7 papers) and Health Systems, Economic Evaluations, Quality of Life (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (6.8k citations), Oncology (2.6k citations), Hematology (992 citations), Genetics (481 citations) and Cancer Research (605 citations). Michael Crump has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include John G. Kuruvilla, Armand Keating, Melania Pintilie, Richard W. C. Tsang, Christian Gisselbrecht, David C. Hodgson, Mary Krystyna Gospodarowicz, Bertrand Coiffier, Annette E. Hay and Woodrow A. Wells. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, British Journal of Haematology and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact